Insulin Delivery Using Microneedles in Type 1 Diabetes
| Status: | Completed |
|---|---|
| Conditions: | Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 8 - 18 |
| Updated: | 1/1/2014 |
| Start Date: | September 2008 |
| End Date: | July 2013 |
| Contact: | Nicholas Raviele, BS |
| Email: | nicholas.raviele@emory.edu |
| Phone: | 404-727-3189 |
The goal of this study is to determine if microneedles can effectively and painlessly
deliver insulin to children and young adults with type 1 diabetes.
deliver insulin to children and young adults with type 1 diabetes.
Inclusion Criteria:
- ≥ 8 years of age
- <19 years of age
- T1D for at least 2 years
- Uses a conventional, FDA-approved insulin pump for the past year
- Uses Lispro insulin
- Mean hemoglobin A1C ≤ 8.5 % for the past year
- Body mass index ≤ 85th percentile for age
- Understand and be willing to adhere to the study protocol
Exclusion Criteria:
- T2D
- Acanthosis nigricans
- Clinically significant major organ system disease
- On glucocorticoid therapy
- Insulin requirement ≥ 150 U/day
- Illness on the day of the study
- Cognitive impairment (IQ < 85 or > 2 grades behind age-appropriate grade)
- Pregnant or breast-feeding (if female).
We found this trial at
1
site
Emroy University Emory University, recognized internationally for its outstanding liberal artscolleges, graduate and professional schools,...
Click here to add this to my saved trials
